Avidity Partners Management LP Axsome Therapeutics, Inc. Transaction History

Avidity Partners Management LP

$2.03 Billion
Q2 2024

A detailed history of Avidity Partners Management LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 376,000 shares of AXSM stock, worth $34 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares

376,000

Previous 431,000 12.76%

Holding current value

$34 Million

Previous $34.4 Million 11.99%

% of portfolio

1.49%

Previous 1.33%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $3.61 Million - $4.43 Million	-55,000 Reduced 12.76%	376,000 $30.3 Million
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $1.97 Million - $2.77 Million	-28,400 Reduced 6.18%	431,000 $34.4 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $9.34 Million - $13.6 Million	162,600 Added 54.78%	459,400 $36.6 Million
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $17.2 Million - $20.4 Million	-248,200 Reduced 45.54%	296,800 $20.7 Million
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $4.33 Million - $6.7 Million	-74,200 Reduced 11.98%	545,000 $39.2 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $2.97 Million - $3.81 Million	-50,800 Reduced 7.58%	619,200 $38.2 Million
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $34.7 Million - $69.2 Million	-868,600 Reduced 56.45%	670,000 $51.7 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $55.5 Million - $107 Million	1,538,600 New	1,538,600 $68.7 Million
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $15.5 Million - $33.2 Million	-711,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $1.52 Million - $2.65 Million	-64,000 Reduced 8.26%	711,000 $29.4 Million
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $23.8 Million - $33.6 Million	775,000 New	775,000 $29.3 Million
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $7.82 Million - $10.2 Million	-118,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $19.6 Million - $24.6 Million	-286,900 Reduced 70.86%	118,000 $8.41 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $10.4 Million - $20.5 Million	207,900 Added 105.53%	404,900 $33.3 Million
Q1 2020 Jun 17, 2020	BUY	$41.2 - $101.31 $8.12 Million - $20 Million	197,000 New	197,000 $11.6 Million

Others Institutions Holding AXSM

# of Institutions

288

Shares Held

40.4M

Call Options Held

365K

Put Options Held

428K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.88B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Account

Avidity Partners Management LP Axsome Therapeutics, Inc. Transaction History